Asthma Patients
13
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)
Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting
The Effect of Thyme Oil in Asthmatic Patients
A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses
Pharmacist Counseling & Self-Management Program for Asthma Patients in a Midwest Chain Pharmacy, USA
Effects of Buteyko Breathing Exercise in Children With Uncontrolled Asthma
Effectiveness of Asthma Education Program Based on the Roy Adaptation Model
The Effect of Deep Tissue Massage on Respiratory Parameters in People With Asthma
ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression
EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 1.
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients